Sand Hill Global Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-13,581
Closed -$2.59M 114
2018
Q3
$2.59M Buy
13,581
+581
+4% +$107K 0.25% 59
2018
Q2
$2.17M Buy
13,000
+11,621
+843% +$1.87M 0.21% 59
2018
Q1
$232K Sell
1,379
-12,134
-90% -$2.04M 0.22% 72
2017
Q4
$2.21M Sell
13,513
-1,310
-9% -$235K 0.22% 57
2017
Q3
$3.04M Buy
14,823
+13
+0.1% +$3.02K 0.32% 55
2017
Q2
$3.6M Buy
+14,810
New +$3.48M 0.41% 55

Other funds holding AGN

Sand Hill Global Advisors's AGN Position: Q4 2018 in Review

Sand Hill Global Advisors sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 13,581 shares — an estimated $2.59M sold.

Sand Hill Global Advisors first reported a position in AGN in Q2 2017 and held it in 6 quarters. The position peaked at $3.6M in Q2 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Sand Hill Global Advisors reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Sand Hill Global Advisors sold 13,581 Allergan plc shares in Q4 2018, an estimated $2.59M.
  • Sand Hill Global Advisors first reported a position in Allergan plc in Q2 2017 and held it in 6 quarters.
  • Sand Hill Global Advisors's Allergan plc position peaked at $3.6M in Q2 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Sand Hill Global Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.